2012
DOI: 10.1152/ajpregu.00194.2011
|View full text |Cite
|
Sign up to set email alerts
|

Experimental mild renal insufficiency mediates early cardiac apoptosis, fibrosis, and diastolic dysfunction: a kidney-heart connection

Abstract: Impaired renal function with loss of nephron number in chronic renal disease (CKD) is associated with increased cardiovascular morbidity and mortality. However, the structural and functional cardiac response to early and mild reduction in renal mass is poorly defined. We hypothesized that mild renal impairment produced by unilateral nephrectomy (UNX) would result in early cardiac fibrosis and impaired diastolic function, which would progress to a more global left ventricular (LV) dysfunction. Cardiorenal funct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
57
0

Year Published

2012
2012
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 71 publications
(62 citation statements)
references
References 31 publications
5
57
0
Order By: Relevance
“…TGF-b is a known key player in solid organ fibrosis 42 and has been implicated in the development of UC. 31,43 We observed a significant upregulation of TGF-b in both rat models of UC. Additionally, UC was accompanied by re-expression of the fetally expressed b-myosin heavy chain and increased cardiac expression of brain natriuretic peptide, both of which have been linked to cardiac fibrosis, hypertrophy, and UC.…”
Section: Discussionmentioning
confidence: 69%
“…TGF-b is a known key player in solid organ fibrosis 42 and has been implicated in the development of UC. 31,43 We observed a significant upregulation of TGF-b in both rat models of UC. Additionally, UC was accompanied by re-expression of the fetally expressed b-myosin heavy chain and increased cardiac expression of brain natriuretic peptide, both of which have been linked to cardiac fibrosis, hypertrophy, and UC.…”
Section: Discussionmentioning
confidence: 69%
“…CKD carries a higher cardiovascular comorbid burden including congestive heart failure (CHF), the prevalence of which is as high as 13%-20% in stage 4-5 CKD patients compared with 1%-2% in those without CKD (2)(3)(4). Reduction in nephron mass induces early cardiac fibrosis, myocardial hypertrophy, and diastolic impairment that portend an increased risk for heart failure (HF) in the CKD population (5)(6)(7). Adequate renin-angiotensin-aldosterone (RAAS) blockade with angiotensin-converting enzyme inhibitors (ACEIs), angiotensin-receptor blockers (ARBs), mineralocorticoid receptor antagonists, and b-adrenergic antagonists remains the mainstay of treatment for CHF (8).…”
Section: Introductionmentioning
confidence: 99%
“…It is possible that loss of functioning myocardium in mild -moderate CKD and replacement fibrosis may lead to reduction in LV mass and size. 26 In a rodent model of mild renal insufficiency, dUTP nick-end labeling (TUNEL) staining revealed increased apoptosis and loss of myocardium. 26 There is an early increase in intravascular volume of mild-to-moderate CKD in the presence of activated renin-angiotensin-aldosterone system.…”
Section: Discussionmentioning
confidence: 99%
“…26 In a rodent model of mild renal insufficiency, dUTP nick-end labeling (TUNEL) staining revealed increased apoptosis and loss of myocardium. 26 There is an early increase in intravascular volume of mild-to-moderate CKD in the presence of activated renin-angiotensin-aldosterone system. 27 This may lead to remodeling in the early phase of CKD.…”
Section: Discussionmentioning
confidence: 99%